Virtual Support
December 12, 2020
How the EMA plans to help researchers and developers make better medicines
0 min read
November 2020
In November’s issue of The Small Molecule Manufacturer, industry experts discuss best practices for handling HPAPIs in our cover feature. We also explore how 3D printing can be used to improve therapeutic options for the blind and visually impaired in the Next Big Thing, as well as how drug developers can best handle solubility-challenged molecules. And we sit down with Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia, who explains how the COVID-19 pandemic has affected her first year at the company.
A Tactile Experience
November 7, 2020
How can we improve medication adherence among blind and partially sighted patients?
1 min read
Think Small
November 6, 2020
Micro-feeder eases the handling of small quantities of powder
1 min read
Fancy a Game of Ping-Pong?
November 5, 2020
When following COVID-19 research, it’s hard to keep your eye on the ball...
1 min read
From Brick Dust to Blockbuster
November 4, 2020
How can we best deliver solubility-challenged small molecules to the clinic?
1 min read
Business & Regulation
Business & Trends
Facilities & Equipment
Technology & Manufacturing
Regulation & Standards
Small Molecules
Adapting to Change
October 30, 2020
Sitting Down With… Kimberly Eggers, Vice-president of Medical and Clinical Affairs, Aprecia, Blue Ash, Ohio, USA
1 min read
The Gut Response
October 27, 2020
Shedding light on the microbiome’s interaction with oral medicines
1 min read
Getting a Handle on High Potency
August 1, 2020
We need to optimize and then accelerate HPAPI drug product development
0 min read
